Vaxxas Appoints Dr. Rochelle Chaiken as Chief Medical Officer
Vaxxas hires former Pfizer medical executive Dr Rochelle Chaiken as its chief medical officer; the announcement also recounts the biotech's founding financing and later rounds.
Company
Every investor coverage indicates participated in a round World Health Organization (WHO) raised.
Companies World Health Organization (WHO) acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming World Health Organization (WHO). Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vaxxas hires former Pfizer medical executive Dr Rochelle Chaiken as its chief medical officer; the announcement also recounts the biotech's founding financing and later rounds.
Vaxxas completed a US$23 million (A$34 million) financing led by OneVentures and UniQuest to advance its needle-free vaccine clinical programs, including a COVID-19 candidate, with board members, management and individual investors also participating.
Also OneVentures portfolio·Brandon Capital portfolio·@AuManufacturing·SmartCompany·Techboard·@AuManufacturing